| A team of students, including
Jeff Gross, a Biomedical Engineering doctoral student working in the lab
of Georgia Tech/Emory Center for the Engineering of Living Tissues (GTEC)
thrust group leader Athanassios Sambanis, created a conceptual company
based on an innovative GTEC technology. The company, EvIslet™, is
a medical device research and development company with a unique ability
in developing diagnostic devices for cell implantation. Potential
markets for company products include the areas of diabetes, liver transplants,
and stem cell research.
The student team, including
Gross and three other students in law and business, created the company
as part of their coursework in Georgia Tech’s TI:GER Team program (Technology
Innovation: Generating Economic Results). By working with GTEC-developed
technology and their TI:GER Team, the students gained real-world experience
in commercializing new technologies and delivering innovative products
to the marketplace.
Mentored by Rafael Andino
of Biofisica, a GTEC Industrial Partner, the team took second place and
$3,000 in the 2006 Georgia Tech Business Plan Competition.
Additionally, in Fall 2006,
EvIslet’s core technology was selected by the GTEC Industrial Partners
to receive a seed grant to further investigate the potential of the concept,
and hopefully to advance the commercialization process. |
